NPC
BBH icon

National Planning Corporation’s VanEck Biotech ETF BBH Stock Holding History

National Planning Corporation’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,864
Closed -$454K – 665
2016
Q2 		$454K Buy
+3,864
New +$412K 0.04% 397
2016
Q1 		– Sell
-9,279
Closed -$909K – 651
2015
Q4 		$909K Sell
9,279
-3,043
-25% -$373K 0.07% 263
2015
Q3 		$1.57M Sell
12,322
-357
-3% -$47.3K 0.14% 156
2015
Q2 		$1.72M Buy
12,679
+675
+6% +$89.7K 0.15% 141
2015
Q1 		$1.52M Buy
12,004
+1,753
+17% +$220K 0.14% 153
2014
Q4 		$1.22M Sell
10,251
-132
-1% -$14.9K 0.09% 210
2014
Q3 		$1.1M Sell
10,383
-91
-0.9% -$9.21K 0.08% 235
2014
Q2 		$999K Buy
10,474
+2,160
+26% +$194K 0.08% 245
2014
Q1 		$776K Buy
8,314
+2,688
+48% +$261K 0.07% 280
2013
Q4 		$502K Buy
5,626
+1,569
+39% +$131K 0.04% 361
2013
Q3 		$340K Buy
+4,057
New +$319K 0.03% 455

Other funds holding BBH

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
TH
Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

National Planning Corporation's BBH Position: Q3 2016 in Review

National Planning Corporation sold out of VanEck Biotech ETF (BBH) in Q3 2016, closing a stake of 3,864 shares — an estimated $454K sold.

National Planning Corporation first reported a position in BBH in Q3 2013 and held it in 11 quarters. The position peaked at $1.72M in Q2 2015. 79 funds tracked by Wall St. Rank hold BBH as of Q3 2016.

  • National Planning Corporation reported no remaining VanEck Biotech ETF position as of Q3 2016 after selling out during the quarter.
  • National Planning Corporation sold 3,864 VanEck Biotech ETF shares in Q3 2016, an estimated $454K.
  • National Planning Corporation first reported a position in VanEck Biotech ETF in Q3 2013 and held it in 11 quarters.
  • National Planning Corporation's VanEck Biotech ETF position peaked at $1.72M in Q2 2015.
  • 79 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2016.

Based on National Planning Corporation's 13F filing for Q3 2016, filed 10 Nov 2016.